Ryuichi Nakamura

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Preclinical evaluation and mechanistic analysis of antitumor effects of the novel anti-CD147 antibody DS-1471a in liver cancer models.

Preclinical evaluation and mechanistic analysis of antitumor effects of the novel anti-CD147 antibody DS-1471a in liver cancer models.

Journal: Investigational new drugs

Published: February 20, 2026

The Impact of HER3 Dynamics Altered by HER3-DXd Alone and in Combination with Driver Oncogene Inhibitors on HER3-DXd Efficacy.

The Impact of HER3 Dynamics Altered by HER3-DXd Alone and in Combination with Driver Oncogene Inhibitors on HER3-DXd Efficacy.

Journal: International journal of molecular sciences

Published: December 23, 2025

Human epidermal growth factor receptor 3 expression in patients with epithelial ovarian cancer: a potential target for ovarian mucinous and clear cell carcinoma.

Human epidermal growth factor receptor 3 expression in patients with epithelial ovarian cancer: a potential target for ovarian mucinous and clear cell carcinoma.

Journal: International journal of clinical oncology

Published: August 03, 2024

A novel T cell-redirecting anti-GPRC5D × CD3 bispecific antibody with potent antitumor activity in multiple myeloma preclinical models.

A novel T cell-redirecting anti-GPRC5D × CD3 bispecific antibody with potent antitumor activity in multiple myeloma preclinical models.

Journal: Scientific reports

Published: November 08, 2023

Involvement of Degenerating 21.5 kDa Isoform of Myelin Basic Protein in the Pathogenesis of the Relapse in Murine Relapsing-Remitting Experimental Autoimmune Encephalomyelitis and MS Autopsied Brain.

Involvement of Degenerating 21.5 kDa Isoform of Myelin Basic Protein in the Pathogenesis of the Relapse in Murine Relapsing-Remitting Experimental Autoimmune Encephalomyelitis and MS Autopsied Brain.

Journal: International journal of molecular sciences

Published: March 31, 2023

Safety assessment of a novel C-type natriuretic peptide derivative and the mechanism of bone- and cartilage-specific toxicity.

Safety assessment of a novel C-type natriuretic peptide derivative and the mechanism of bone- and cartilage-specific toxicity.

Journal: PloS one

Published: May 24, 2019

ASB20123: A novel C-type natriuretic peptide derivative for treatment of growth failure and dwarfism.

ASB20123: A novel C-type natriuretic peptide derivative for treatment of growth failure and dwarfism.

Journal: PloS one

Published: December 25, 2018

Exogenous C-type natriuretic peptide restores normal growth and prevents early growth plate closure in its deficient rats.

Exogenous C-type natriuretic peptide restores normal growth and prevents early growth plate closure in its deficient rats.

Journal: PloS one

Published: May 18, 2018

Heterogeneity of auto-antibodies against nAChR in myasthenic serum and their pathogenic roles in experimental autoimmune myasthenia gravis.

Heterogeneity of auto-antibodies against nAChR in myasthenic serum and their pathogenic roles in experimental autoimmune myasthenia gravis.

Journal: Journal of neuroimmunology

Published: February 20, 2018

Development of a novel immunoassay to select antibodies against intact membrane antigens by using the homogeneous AlphaLISA system.

Development of a novel immunoassay to select antibodies against intact membrane antigens by using the homogeneous AlphaLISA system.

Journal: Journal of bioscience and bioengineering

Published: February 08, 2018

Rats deficient C-type natriuretic peptide suffer from impaired skeletal growth without early death.

Rats deficient C-type natriuretic peptide suffer from impaired skeletal growth without early death.

Journal: PloS one

Published: December 15, 2017

Analysis of peripheral B cells and autoantibodies against the anti-nicotinic acetylcholine receptor derived from patients with myasthenia gravis using single-cell manipulation tools.

Analysis of peripheral B cells and autoantibodies against the anti-nicotinic acetylcholine receptor derived from patients with myasthenia gravis using single-cell manipulation tools.

Journal: PloS one

Published: December 13, 2016

Showing 1-12 of 13

Last Updated: 09/26/2026